Antiphospholipid syndrome (APS) is an autoimmune thrombophilia propelled by circulating
antiphospholipid antibodies that herald vascular thrombosis and obstetrical complications …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
recurrent vascular thrombosis and miscarriages in the absence of known causes. Antibodies …

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown
aetiology. It is characterized by impaired tolerance to a wide range of cellular and …

Background The antiphospholipid syndrome (APS) is classified by the presence of
antiphospholipid antibodies (aPL) and thrombotic and/or adverse obstetric outcomes. The …

The definition of acute and chronic antiphospholipid syndrome (APS) nephropathy was
recently updated using a multiphase methodology in the context of the development of the …

Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Abstract Purpose of the Review Thrombotic risk assessment in antiphospholipid positive
(aPL+) subjects is a major challenge, and the study of in vitro thrombin generation (thrombin …

Antiphospholipid syndrome (APS) is a rare autoimmune disorder with complex
pathogenesis. Studies have shown that oxidative stress may contribute to APS …

Objectives: A growing body of studies related to antiphospholipid syndrome (APS) have
been published in recent years. Nevertheless, there is a lack of visualized and systematic …

Anti-DNA antibodies are hallmark autoantibodies produced in systemic lupus erythematosus
(SLE), but their pathogenetic role is not fully understood. Accumulating evidence suggests …